drugset / Trial / NCT05725252
To Evaluate the Safety and the Pharmacokinetics of NVP-2203
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics after administration of NVP-2203.
Timeline
- Start
- 2023-05-28
- Primary completion
- 2023-06-11
- Completion
- 2023-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NVP-2203-R | Unknown | — | Oral |
| Subject | NVP-2203-R1 | Unknown | — | Oral |
| Subject | NVP-2203-R2 | Unknown | — | Oral |
Indications
No indication recorded.